tradingkey.logo

BUZZ-LanzaTech rises on synthetic biology unit spin-out

ReutersJan 22, 2025 1:10 PM

** Carbon recycling firm LanzaTech Global's LNZA.O shares rise 5.3% to $1.58 premarket

** On Tuesday, LNZA said it is spinning out its synthetic biology platform, LanzaX, into a joint venture with Tharsis Capital to accelerate project development and financing

** The spin-out of LanzaX is expected to reduce LNZA's cost structure by ~$8 mln annually, company said

** LNZA said it's contributing its existing synbio contracts, 100+ developed molecules, and commercial expertise to LanzaX to accelerate product development

** LNZA said it is appointing a new interim chief financial officer, Justin Pugh, to focus on cost reductions and resource reallocation for its biorefining business

** LNZA fell ~71% in 2024

(Reporting by Kamal Choudhury in Bengaluru)

((Kamal.Choudhury@thomsonreuters.com;))

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI